Cutler Group’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-11,900
Closed -$97K 4923
2020
Q1
$97K Buy
+11,900
New +$828K 0.01% 1346
2019
Q4
Sell
-100
Closed -$1K 4632
2019
Q3
$1K Sell
100
-100
-50% -$6.71K ﹤0.01% 3847
2019
Q2
$2K Buy
200
+100
+100% +$7.93K ﹤0.01% 3666
2019
Q1
$1K Buy
+100
New +$10.4K ﹤0.01% 3822
2018
Q4
Sell
-700
Closed -$1K 4627
2018
Q3
$1K Hold
700
﹤0.01% 3891
2018
Q2
$3K Sell
700
-2,000
-74% -$219K ﹤0.01% 3436
2018
Q1
$2K Buy
2,700
+1,000
+59% +$77.4K ﹤0.01% 3854
2017
Q4
$1K Sell
1,700
-1,100
-39% -$73.6K ﹤0.01% 4595
2017
Q3
$17K Sell
2,800
-1,000
-26% -$59.1K ﹤0.01% 3292
2017
Q2
$16K Buy
+3,800
New +$234K ﹤0.01% 3666

Other funds holding USNA

Cutler Group's USNA Position: Q1 2021 in Review

Cutler Group sold out of Usana Health Sciences (USNA) in Q1 2021, closing a stake of 60 shares — an estimated $4K sold.

Cutler Group first reported a position in USNA in Q2 2017 and held it in 10 quarters. The position peaked at $142K in Q3 2017. 198 funds tracked by Wall St. Rank hold USNA as of Q1 2021.

  • Cutler Group reported no remaining Usana Health Sciences position as of Q1 2021 after selling out during the quarter.
  • Cutler Group sold 60 Usana Health Sciences shares in Q1 2021, an estimated $4K.
  • Cutler Group first reported a position in Usana Health Sciences in Q2 2017 and held it in 10 quarters.
  • Cutler Group's Usana Health Sciences position peaked at $142K in Q3 2017.
  • 198 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2021.

Based on Cutler Group's 13F filing for Q1 2021, filed 26 Apr 2021.